Literature DB >> 4597226

Minimization: a new method of assigning patients to treatment and control groups.

D R Taves.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4597226     DOI： 10.1002/cpt1974155443

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  176 in total

1.  Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation.

Authors:  Victor A Levin; Surasak Phuphanich; W K Alfred Yung; Peter A Forsyth; Rolando Del Maestro; James R Perry; Gregory N Fuller; Mark Baillet
Journal:  J Neurooncol       Date:  2006-04-25       Impact factor: 4.130

2.  Impact of two psychosocial interventions on white and African American family caregivers of individuals with dementia.

Authors:  Louis Burgio; Alan Stevens; Delois Guy; David L Roth; William E Haley
Journal:  Gerontologist       Date:  2003-08

3.  Quantifying the cost in power of ignoring continuous covariate imbalances in clinical trial randomization.

Authors:  Jody Ciolino; Wenle Zhao; Renee' Martin; Yuko Palesch
Journal:  Contemp Clin Trials       Date:  2010-11-13       Impact factor: 2.226

4.  Choice of statistical model for cost-effectiveness analysis and covariate adjustment: empirical application of prominent models and assessment of their results.

Authors:  Theodoros Mantopoulos; Paul M Mitchell; Nicky J Welton; Richard McManus; Lazaros Andronis
Journal:  Eur J Health Econ       Date:  2015-10-07

5.  The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men.

Authors:  Peter J Snyder; Susan S Ellenberg; Glenn R Cunningham; Alvin M Matsumoto; Shalender Bhasin; Elizabeth Barrett-Connor; Thomas M Gill; John T Farrar; David Cella; Raymond C Rosen; Susan M Resnick; Ronald S Swerdloff; Jane A Cauley; Denise Cifelli; Laura Fluharty; Marco Pahor; Kristine E Ensrud; Cora E Lewis; Mark E Molitch; Jill P Crandall; Christina Wang; Matthew J Budoff; Nanette K Wenger; Emile R Mohler; Diane E Bild; Nakela L Cook; Tony M Keaveny; David L Kopperdahl; David Lee; Ann V Schwartz; Thomas W Storer; William B Ershler; Cindy N Roy; Leslie J Raffel; Sergei Romashkan; Evan Hadley
Journal:  Clin Trials       Date:  2014-06       Impact factor: 2.486

6.  Change in Patient Outcomes After Augmenting a Low-level Implementation Strategy in Community Practices That Are Slow to Adopt a Collaborative Chronic Care Model: A Cluster Randomized Implementation Trial.

Authors:  Shawna N Smith; Daniel Almirall; Katherine Prenovost; Celeste Liebrecht; Julia Kyle; Daniel Eisenberg; Mark S Bauer; Amy M Kilbourne
Journal:  Med Care       Date:  2019-07       Impact factor: 2.983

7.  Individualized anemia management reduces hemoglobin variability in hemodialysis patients.

Authors:  Adam E Gaweda; George R Aronoff; Alfred A Jacobs; Shesh N Rai; Michael E Brier
Journal:  J Am Soc Nephrol       Date:  2013-09-12       Impact factor: 10.121

8.  Minimal sufficient balance-a new strategy to balance baseline covariates and preserve randomness of treatment allocation.

Authors:  Wenle Zhao; Michael D Hill; Yuko Palesch
Journal:  Stat Methods Med Res       Date:  2012-01-26       Impact factor: 3.021

9.  Second-order interactions with the treatment groups in controlled clinical trials.

Authors:  Shyang-Yun Pamela K Shiao; Chul W Ahn; Kouhei Akazawa
Journal:  Comput Methods Programs Biomed       Date:  2007-02-14       Impact factor: 5.428

10.  1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis.

Authors:  J C Gallagher; C M Jerpbak; W S Jee; K A Johnson; H F DeLuca; B L Riggs
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.